Biyi

Biyi (Shanghai) Biotechnology is a specialized drug discovery and service company based in Shanghai, China, focusing on high-throughput screening (HTS) technologies. The company provides a comprehensive platform for challenging drug targets, including G protein-coupled receptors (GPCRs), ion channels, and transporters. Biyi offers a range of services such as assay development, compound library screening, and lead optimization to global pharmaceutical and biotech partners. By integrating its proprietary screening platforms with deep expertise in membrane protein biology, Biyi supports both external collaborations and internal research initiatives aimed at developing novel small molecule therapeutics for oncology, metabolic diseases, and neurological disorders.